![Nia Tatsis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 23 M $ in data 30/06/2026
Nia Tatsis currently serves as Chief Regulatory & Quality Officer, Director, EVP at Vertex Pharmaceuticals, Inc. since 2025, Independent Director at Odyssey Therapeutics, Inc. since 2025, and Member-Leadership Council at the International Institute of New England since 2021.
Former roles include Director at Verve Therapeutics, Inc. from 2024 to 2025 and Vice President & Head-Global Regulatory Affairs at Genzyme Corp.
from 2014 to 2017.
Education includes undergraduate studies at Temple University (Pennsylvania) and a doctorate from the University of Vermont.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/07/2026 | 45.321 ( 0,02% ) | 23 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Direttore/Membro del Consiglio | 10/10/2025 |
| ODYSSEY THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/09/2025 |
International Institute of New England
 International Institute of New England Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for immigration and foreign communities | Corporate Officer/Principal | 01/01/2021 |
| Società | Posizione | Fine |
|---|---|---|
| VERE THER | Direttore/Membro del Consiglio | 25/07/2025 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute of New England
International Institute of New England Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for immigration and foreign communities | Commercial Services |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
